Delivery Order SPE2DB22D2007-SPE2DB25FJ1XW
Award Date 5/30/25
Potential Completion Date 6/2/25
Potential Value $1K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Contrave ER 8-90 mg tablets (120 count) with a firm fixed price ceiling value of $12,096.02. The delivery order, issued on November 7, 2025, with an ultimate completion date of November 10, 2025, represents a non-competitive award under the company's existing contract vehicle with DLA. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken,...
- The Defense Logistics Agency (DLA) awarded a $15,022.85 delivery order to AmerisourceBergen Drug Corp for Contrave ER 8-90 mg tablets (120-count) on November 7, 2025, with an ultimate completion date of November 10, 2025. This firm fixed-price, non-set-aside contract is performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a single transaction under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $9,334.50 to AmerisourceBergen Drug Corp for the supply of Contrave ER 8-90 mg tablets (120 count). This competitively awarded, non-set-aside contract carries a firm fixed price structure with an ultimate completion date of September 25, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. Contrave is an FDA-approved pharmaceutical product used for weight...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Contrave ER 8-90 mg tablets (120-count units) with a ceiling value of $9,610.38. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was made through open competition. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of August 13, 2025....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Contrave ER 8-90 mg tablets (120-count units) valued at $7,553.07 under a firm fixed-price contract. This is a non-set-aside, competitively awarded delivery order with an ultimate completion date of September 4, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a major pharmaceutical distributor and critical vendor for federal medical...
- The Defense Logistics Agency awarded a $7,142.54 delivery order to AmerisourceBergen Drug Corp on September 24, 2025, for the supply of Contrave ER 8-90 mg tablets (120 count). This is a firm fixed-price delivery order with no set-aside designation, indicating the award was made through open competition. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of September 25, 2025. This delivery order is...
- The Defense Logistics Agency awarded a delivery order valued at $4,507.62 to AmerisourceBergen Drug Corp for the supply of Contrave ER 8-90 mg tablets (120 count) under a firm fixed-price contract. The award was issued on November 4, 2025, with an ultimate completion date of November 5, 2025. This non-set-aside delivery order represents a small-value pharmaceutical transaction executed through AmerisourceBergen's existing contract vehicle with the DLA. AmerisourceBergen Drug Corp,...
- The Defense Logistics Agency awarded a delivery order valued at $6,894.95 to AmerisourceBergen Drug Corp for Contrave ER 8-90 mg tablets (120-count supply) on July 18, 2025, with completion expected by July 21, 2025. This competitively awarded, firm fixed-price delivery order was issued under a non-set-aside solicitation and represents a continuation of the company's extensive pharmaceutical supply relationship with DLA. The product will be delivered to AmerisourceBergen's corporate office...
- The Defense Logistics Agency awarded a $5,214.68 delivery order to AmerisourceBergen Drug Corp on September 22, 2025, for the supply of Contrave ER 8-90 mg tablets (120-count units). This is a firm fixed-price, non-competitive award with an ultimate completion date of September 23, 2025. The pharmaceutical product will be delivered to the Conshohocken, Pennsylvania location, where AmerisourceBergen Drug Corp maintains its corporate headquarters. As a child contract, this delivery order is issued...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of Contrave ER 8-90 mg tablets (120 count) under a firm fixed-price contract valued at $13,888.78. The delivery order, which represents a child contract under AmerisourceBergen's larger prime vendor agreement, has an ultimate completion date of September 15, 2025. This award was made through open competition with no set-aside designation. AmerisourceBergen, headquartered...